Cargando…
The when, why and whom to biopsy of type 1 diabetes mellitus children with positive anti-tissue transglutaminase serology
Autor principal: | Guandalini, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645000/ https://www.ncbi.nlm.nih.gov/pubmed/37787345 http://dx.doi.org/10.4103/sjg.sjg_253_23 |
Ejemplares similares
-
Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020) -
Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017) -
Laparoscopy in Blunt Abdominal Trauma: for Whom? When?and Why?
por: Justin, Viktor, et al.
Publicado: (2017) -
To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020) -
In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)